Posts

New Developments with Operational Updates in Generic Drugs Market

Generic drugs market growth is buoyed by increasing number of patented expiries for drugs each year. According to the IMS data small-molecule products worth US$ 121 Bn are expected to lose patents in developed markets, such as U.S and Europe between 2014 and 2018. The IMS also forecasts that biologic products valued at US$ 48 Bn are expected to lose patent protection over the next three years i.e from 2017 and 2020, which is expected to drive growth of the generic drugs market. Global generics market is highly competitive with many Asia Pacific companies entering the developed markets such as the U.S., Germany, France, and UK. Recent past has witnessed spurt in mergers and acquisitions between generic drug manufacturers, with major players focusing on enhancing their product portfolio through such inorganic strategies. For instance, Teva Pharmaceutical Industries Pvt. Ltd., Pfizer, Inc., Mylan, Sun Pharmaceutical, and Fresenius Kabi entered into acquisitions to increase their rev
Post a Comment
Read more

Biomarkers Market Business Opportunties and Growth 2018 to 2026

Biomarkers are used for diagnosis and drug development, as these biomarkers can indicate diseases in the body. Furthermore, biomarkers can be any specific cells, molecules, genes or gene products, enzymes or hormones. Biomarker-based test are precise and rapid, which help in early prediction of susceptibility, prognosis, diagnosis, and treatment of disease. Hence, increasing research and development activities for identifying new biomarkers to diagnose or treat diseases is expected to be major factor growth of the market. Biomarker are required for personalized medicine as it helps to identify the unique characteristics of the disease and helps to tailor medicine according to the need of patients. Hence, to cater to demand for personalized medicines, pharmaceutical companies are investing in R&D, which is expected to lead to identification of novel biomarkers, thus aiding in growth of the market. Request Sample Copy Of This Research Report: https://www.coherentmarketins
Post a Comment
Read more

Cardiovascular Information System Market Cost Analysis And Growth Factor Report by 2026

Cardiovascular information system is a web-based solution that provides an end-to-end management platform and allows cardiologists and clinical staff to efficiently access post-procedural phases of patient care, including imaging, reporting, hemodynamics, analytics, and others. McKesson Cardiology streamlines data management into a single Cardiovascular Information System (CVIS), which allows to collect data and help improve the quality of care provided to patients. Market Dynamics Continuous advancement of the database modules within the CVIS that covers the entire spectrum of cardiovascular activities, including both invasive and non-invasive is expected to propel growth of the market over the forecast period. Furthermore, increasing imaging and diagnostic tests in various regions are expected to drive growth of cardiovascular information system market. For instance, according to the National Health Service, England, 39.8 million imaging tests were reported in England in
Post a Comment
Read more

Personalized Cell Therapy Market Huge Growth Opportunity Trend By 2018-2026

The patient-tailored therapies for the treatment of variety of disease are known as personalized cell therapy. The personalized cell therapy is based on genomic profile, and disease prevalence/severity and the drug developed by this therapy target the patients who matches the specific disease physiopathology and/or patient characteristics. The personalized cell therapy is mainly developed for the treatment of high unmet need disease such as cancer, also it comprises drugs for treatment of other diseases such as autoimmune disease, cardiovascular, neurologic and inflammatory disease. Personalized cell therapy also finds application in the area of platelet transfusions, packed red cell transfusions, bone marrow transplantation and in organ transplantation. Request For Sample Copy of This Research Report: https://www.coherentmarketinsights.com/insight/request-sample/204 Personalized Cell Therapy Market Dynamics The continuous development in science and technology sec
Post a Comment
Read more

Medical Cannabis Market: Current Outlook Of Industry & Forecast 2018-2026

According to the U.S., marijuana was the most widely used drug globally in 2014 with around 183 million users. Such a large user base makes it highly lucrative taxable opportunity, which is influencing various governments worldwide to initiate studies regarding legalization of the drug for medicinal use. The National Institute on Drug Abuse is conducting research on cannabis (marijuana) to treat numerous diseases and conditions such as autoimmune disease, pain, inflammation, seizures, mental disorders, and substance abuse disorders. Regulatory compliance is a key factor that influences cost, quality, and safety of cannabis (marijuana) medicines, as well as the capacity for the manufacturers in the medical cannabis market to be responsive, scalable, and innovative. Market Dynamics According to the Medical Marijuana, Inc., an estimated size of the legal marijuana industry in the U.S. was US$ 7.1 billion in 2016 with increase of 25% Y-o-Y. In 2016, 28 states in the U.S. have l
Post a Comment
Read more

Diabetic Neuropathy Market Size & Share to See Modest Growth Through 2026

Market Overview Diabetic Neuropathy is the damage caused to the nerve due to diabetes which often leads to pain and numbness in feet or lower legs. The pain can be experienced in other parts of the body such as hips, wrist and back depending upon the effect of neuropathy. There are different types of neuropathy such as focal neuropathy, proximal neuropathy, peripheral neuropathy and autonomic neuropathy. An estimated 50% of diabetic population suffers from diabetic neuropathy across the globe. Further, as per CDC estimates, 6-7 people per 1000 diabetic population suffer from diabetic neuropathy in the U.S. Rise in aging population coupled with rise in prevalence of diabetes, the patient pool for diabetic neuropathy will increase significantly, in turn fueling growth of the diabetic neuropathy market. Request Sample Copy Of This B usiness Report: https://www.coherentmarketinsights.com/insight/request-sample/213 New drugs to treat neuropathy pain will alter the current ma
Post a Comment
Read more

e-Prescribing Market Know the Key Growth Drivers Developments and Innovations 2018-2026

e-Prescribing or electronic prescribing is the process of electronically generating and sending a prescription order to a pharmacy directly from the point of care. e-Prescribing improves accuracy, enhances patient safety and quality of care as there are no chances of false interpretation by pharmacist in prescriptions. With the help of e-prescribing tools healthcare providers can enter prescription information into a computer device such as a laptop, tablet, or desktop computer and securely transmit the prescription to pharmacies using a special software program and connectivity to a transmission network. Market Dynamics Significant increase in the number of e-prescriptions in developed economies is attributed to technological developments in healthcare IT and rise in demand of e-prescriptions to reduce the drug abuse. According to Surescripts, e-prescriptions for controlled substances in 2017 accounted for 77.33 million, which increased from 12.8 million in 2015, with a 50
Post a Comment
Read more